Cover Image

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Saved in:
Bibliographic Details
Main Authors: Döhner, Hartmut (Author) , Lübbert, Michael (Author) , Fiedler, Walter (Author) , Fouillard, Loic (Author) , Haaland, Alf (Author) , Brandwein, Joseph M. (Author) , Lepretre, Stephane (Author) , Reman, Oumedaly (Author) , Turlure, Pascal (Author) , Ottmann, Oliver G. (Author) , Müller-Tidow, Carsten (Author) , Krämer, Alwin (Author) , Raffoux, Emmanuel (Author) , Döhner, Konstanze (Author) , Schlenk, Richard F. (Author) , Voß, Florian (Author) , Taube, Tillmann (Author) , Fritsche, Holger (Author) , Maertens, Johan (Author)
Format: Article (Journal)
Language:English
Published: August 2014
In: Blood
Year: 2014, Volume: 124, Issue: 9, Pages: 1426-1433
ISSN:1528-0020
DOI:10.1182/blood-2014-03-560557
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2014-03-560557
Verlag, Volltext: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148765/
Get full text
Author Notes:Hartmut Döhner, Michael Lübbert, Walter Fiedler, Loic Fouillard, Alf Haaland, Joseph M. Brandwein, Stephane Lepretre, Oumedaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller-Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voss, Tillmann Taube, Holger Fritsch, and Johan Maertens

MARC

LEADER 00000caa a2200000 c 4500
001 847581926
003 DE-627
005 20220810034933.0
007 cr uuu---uuuuu
008 160215s2014 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2014-03-560557  |2 doi 
035 |a (DE-627)847581926 
035 |a (DE-576)9847581924 
035 |a (DE-599)GBV847581926 
035 |a (OCoLC)1340145341 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Döhner, Hartmut  |d 1957-  |e VerfasserIn  |0 (DE-588)110666585  |0 (DE-627)729880842  |0 (DE-576)375358846  |4 aut 
245 1 0 |a Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy  |c Hartmut Döhner, Michael Lübbert, Walter Fiedler, Loic Fouillard, Alf Haaland, Joseph M. Brandwein, Stephane Lepretre, Oumedaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller-Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voss, Tillmann Taube, Holger Fritsch, and Johan Maertens 
246 3 3 |a Randomized, phase two trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy 
264 1 |c August 2014 
300 |b Diagramme 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.07.2020 
700 1 |a Lübbert, Michael  |e VerfasserIn  |0 (DE-588)1054105367  |0 (DE-627)79104047X  |0 (DE-576)409999768  |4 aut 
700 1 |a Fiedler, Walter  |e VerfasserIn  |0 (DE-588)1027578748  |0 (DE-627)729427226  |0 (DE-576)373414943  |4 aut 
700 1 |a Fouillard, Loic  |e VerfasserIn  |4 aut 
700 1 |a Haaland, Alf  |e VerfasserIn  |4 aut 
700 1 |a Brandwein, Joseph M.  |e VerfasserIn  |4 aut 
700 1 |a Lepretre, Stephane  |e VerfasserIn  |4 aut 
700 1 |a Reman, Oumedaly  |e VerfasserIn  |4 aut 
700 1 |a Turlure, Pascal  |e VerfasserIn  |4 aut 
700 1 |a Ottmann, Oliver G.  |e VerfasserIn  |0 (DE-588)1073558401  |0 (DE-627)829169059  |0 (DE-576)435167081  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Raffoux, Emmanuel  |e VerfasserIn  |4 aut 
700 1 |a Döhner, Konstanze  |e VerfasserIn  |0 (DE-588)1050325176  |0 (DE-627)783856369  |0 (DE-576)404527671  |4 aut 
700 1 |a Schlenk, Richard F.  |e VerfasserIn  |4 aut 
700 1 |a Voß, Florian  |d 1980-  |e VerfasserIn  |0 (DE-588)140668292  |0 (DE-627)620879297  |0 (DE-576)319340414  |4 aut 
700 1 |a Taube, Tillmann  |d 1967-  |e VerfasserIn  |0 (DE-588)120613735  |0 (DE-627)70487377X  |0 (DE-576)180451316  |4 aut 
700 1 |a Fritsche, Holger  |e VerfasserIn  |0 (DE-588)106242204X  |0 (DE-627)806745959  |0 (DE-576)41834681X  |4 aut 
700 1 |a Maertens, Johan  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 124(2014), 9, Seite 1426-1433  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy 
773 1 8 |g volume:124  |g year:2014  |g number:9  |g pages:1426-1433  |g extent:8  |a Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy 
856 4 0 |u https://doi.org/10.1182/blood-2014-03-560557  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148765/  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200727 
993 |a Article 
994 |a 2014 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |p 11 
999 |a KXP-PPN847581926  |e 3729434160 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"id":{"doi":["10.1182/blood-2014-03-560557"],"eki":["847581926"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 27.07.2020"],"relHost":[{"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"corporate":[{"role":"isb","display":"American Society of Hematology"}],"title":[{"subtitle":"journal of the American Society of Hematology","title_sort":"Blood","title":"Blood"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["266886647"],"issn":["1528-0020"],"zdb":["1468538-3"]},"part":{"pages":"1426-1433","year":"2014","text":"124(2014), 9, Seite 1426-1433","volume":"124","issue":"9","extent":"8"},"note":["Gesehen am 21.04.2023"],"recId":"266886647","disp":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapyBlood","language":["eng"],"titleAlt":[{"title":"Blood online"}],"pubHistory":["1.1946 -"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"person":[{"role":"aut","family":"Döhner","display":"Döhner, Hartmut","given":"Hartmut"},{"role":"aut","given":"Michael","display":"Lübbert, Michael","family":"Lübbert"},{"given":"Walter","display":"Fiedler, Walter","family":"Fiedler","role":"aut"},{"role":"aut","display":"Fouillard, Loic","given":"Loic","family":"Fouillard"},{"role":"aut","family":"Haaland","given":"Alf","display":"Haaland, Alf"},{"role":"aut","family":"Brandwein","given":"Joseph M.","display":"Brandwein, Joseph M."},{"role":"aut","given":"Stephane","display":"Lepretre, Stephane","family":"Lepretre"},{"display":"Reman, Oumedaly","given":"Oumedaly","family":"Reman","role":"aut"},{"family":"Turlure","display":"Turlure, Pascal","given":"Pascal","role":"aut"},{"family":"Ottmann","display":"Ottmann, Oliver G.","given":"Oliver G.","role":"aut"},{"role":"aut","display":"Müller-Tidow, Carsten","given":"Carsten","family":"Müller-Tidow"},{"given":"Alwin","display":"Krämer, Alwin","family":"Krämer","role":"aut"},{"given":"Emmanuel","display":"Raffoux, Emmanuel","family":"Raffoux","role":"aut"},{"display":"Döhner, Konstanze","given":"Konstanze","family":"Döhner","role":"aut"},{"display":"Schlenk, Richard F.","given":"Richard F.","family":"Schlenk","role":"aut"},{"role":"aut","family":"Voß","given":"Florian","display":"Voß, Florian"},{"family":"Taube","display":"Taube, Tillmann","given":"Tillmann","role":"aut"},{"role":"aut","family":"Fritsche","given":"Holger","display":"Fritsche, Holger"},{"display":"Maertens, Johan","given":"Johan","family":"Maertens","role":"aut"}],"name":{"displayForm":["Hartmut Döhner, Michael Lübbert, Walter Fiedler, Loic Fouillard, Alf Haaland, Joseph M. Brandwein, Stephane Lepretre, Oumedaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller-Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voss, Tillmann Taube, Holger Fritsch, and Johan Maertens"]},"origin":[{"dateIssuedDisp":"August 2014","dateIssuedKey":"2014"}],"recId":"847581926","title":[{"title":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy","title_sort":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy"}],"language":["eng"],"titleAlt":[{"title":"Randomized, phase two trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy"}]} 
SRT |a DOEHNERHARRANDOMIZED2014 

Similar Items